Citations

Clear

22 citation(s) found for "Kumar, Naveen".

High‐Throughput Immunoassays for Cavin‐4 IgG: A Diagnostic Tool for Immune‐Mediated Rippling Muscle Disease
LaFrance‐Corey, Reghann G., Kherbek, Haidara , Harinesan, Nimalan, Milone, Margherita , Sarker, Pallab , Karsten, Carley , Dasari, Surendra , Litchy, William J. , Pittock, Sean J. , Mills, John R. , Dubey, Divyanshu , Dubey, Divyanshu , Pittock, S J , Paramasivan, Naveen K, Knight, Andrew M, Liewluck, Teerin , Dubey, Divyanshu , Dubey, Divyanshu , Kherbek, Haidara , Paramasivan, Naveen Kumar , Knight, Andrew M.

Mayo Clinic

Annals of Clinical and Translational Neurology | February 17, 2025 | Volume: 12 | Issue: 4 | Pages: 876-880

10.1002/acn3.70012 | PMID 39957412 Get It

ABSTRACTCavin‐4 was identified as a potential autoantigen for immune‐mediated rippling muscle disease (iRMD). To validate this, we developed and tested various immunoassays, including a cell‐based assay (CBA), cavin‐4 recombinant protein ELISA, and multi‐peptide ELISA. Among 19 iRMD patients, all exhibited muscle rippling, and 13 had percussion‐induced mounding. All immunoassays demonstrated clinical and analytical specificities greater than 95%. The protein ELISA had the highest sensitivity (94.7%) and specificity (99.9%), outperforming CBA (sensitivity 89.5%, specificity 99.6%) and the multi‐peptide ELISA (sensitivity 79.0%, specificity 97.2%). Our results suggest that the cavin‐4 protein ELISA is a promising tool for high‐throughput clinical testing in iRMD.
Clinical Manifestations and Treatment Responses in Pediatric Neurofascin 155-IgG4 Autoimmune Nodopathy
Rashed, Hebatallah R. , Paramasivan, Naveen Kumar , Selcen, Duygu , Dyck, P. James B. , Thakolwiboon, Smathorn , Mauermann, Michelle L. , Mills, John R. , Dubey, Divyanshu , Mills, J R , Dubey, Divyanshu , Mauermann, Michelle L , Thakolwiboon, Smathorn , Paramasivan, Naveen K

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | January 17, 2025 | Volume: 12 | Issue: 2 | Pages: No page available

10.1212/nxi.0000000000200368 | PMID 39823553 Get It

Phenotypic and oncological insights in ANNA1 autoimmunity: Age stratification and biomarker analysis
Paramasivan, Naveen Kumar , Karsten, Carley , Zahid, Anza , Kherbek, Haidara , Ζεκερίδου, Αναστασία , Sista, Sri Raghav, Dasari, Surendra , Mangioris, Georgios , Mills, John R. , Pittock, Sean J, Dubey, Divyanshu , Pittock, Sean J. , Dubey, Divyanshu , Pittock, S J , Masoud, Majed, Kherbek, Haidara , Zekeridou, Anastasia , Knight, Andrew M, McKeon, Andrew , Dubey, Divyanshu , Dubey, Divyanshu , Paramasivan, Naveen K , Masoud, Majed, Knight, Andrew M., McKeon, Andrew

Mayo Clinic

Annals of Clinical and Translational Neurology | November 18, 2024 | Volume: 12 | Issue: 2 | Pages: 280-290

10.1002/acn3.52254 | PMID 39556523 Get It

AbstractObjectiveTo describe the phenotypes, oncological associations, biomarker profiles, and outcomes across different age groups in patients with ANNA1 (anti‐Hu) autoimmunity.MethodsA retrospective review of patients with ANNA1‐IgG in serum/CSF between January 1, 2001, and December 31,2019 was performed. Patients were classified into three groups based on the age of symptom onset. Phage immunoprecipitation sequencing (PhIP‐Seq) and neurofilament light chain (NfL) measurements were done in patient sera/CSF with archived samples.ResultsOf 122 patients, 81 (66%), 20 (16%), and 21 (17%) patients belonged to older adults, young adults, and pediatric groups, respectively. Lung cancer and neuromuscular presentations were more common in older adults (p < 0.001), while limbic encephalitis and neuroblastoma were more common in pediatric patients (p < 0.005). Most young adults (75%) did not have cancer identified. Proportions of patients with a favorable response to immunotherapy were 20%, 30%, and 52% among older adults, young adults, and pediatric groups, respectively. PhIP‐Seq demonstrated significant enrichment for ELAVL4 peptides especially for amino acids 240–289, in the majority of samples evaluated (36/67, 54%). ZIC and SOX2 peptides were significantly enriched in those with central nervous system presentations. Serum NfL levels were elevated in patients with cancer and those with poor long‐term outcomes.InterpretationYoung adults with ANNA1 autoimmunity phenotypically resembled older adults but rarely had an underlying cancer. Pediatric patients frequently presented with limbic encephalitis and neuroblastoma and often responded favorably to immunotherapy. Distinct antigenic signatures may underlie differences in clinical presentations. Serum NfL levels may be a biomarker of poor long‐term outcomes in ANNA1 autoimmunity.
Thrombolysis for Ischemic Stroke Despite Recent Ingestion of Direct Oral Anticoagulants – A Growing Dilemma Also in India
Meinel, Thomas R. , Menon, Bijoy K. , Fischer, Urs , Seiffge, David , Paramasivan, Naveen K, Fischer, Urs , Seiffge, David , Paramasivan, Naveen Kumar

Mayo Clinic

Annals of Indian Academy of Neurology | August 20, 2024 | Volume: 27 | Issue: 4 | Pages: 345-351

10.4103/aian.aian_524_24 | PMID 39196805 Get It

The administration of intravenous thrombolysis (IVT) for patients with acute ischemic stroke who have recently ingested direct oral anticoagulants (DOACs) presents a clinical challenge due to the perceived increased risk of intracranial hemorrhage (ICH). Traditional guidelines from the US and European authorities advise against IVT within 48 h of last DOAC ingestion, unless specific coagulation tests indicate safety. However, emerging observational studies suggest that IVT might be safe in selected patients. A US stroke registry study and a global multicenter cohort study both reported no significant increase in symptomatic ICH among patients on DOACs compared to those not on anticoagulants. A systematic review of all published observational studies further supported these findings, showing comparable bleeding rates and functional outcomes in DOAC-treated patients. Reversal agents like idarucizumab for dabigatran have demonstrated potential in facilitating safer IVT administration, though logistical and cost-related barriers limit their widespread use. The variability in global guidelines reflects differing approaches to risk assessment and resource availability, highlighting the need for individualized treatment decisions. In India, the increasing prevalence of atrial fibrillation and stroke as well as prescription of DOACs necessitate adapted guidelines that consider local health-care infrastructure. Despite the promising observational data, the lack of randomized controlled trials underscores the need for further research to establish robust evidence for IVT use in this context. Collaborative international efforts and inclusion of diverse patient populations in future studies will be crucial to refine treatment protocols and improve outcomes for stroke patients on DOACs.
Plausible role of INPP4A dysregulation in idiopathic pulmonary fibrosis
Arvind, Meghana , Gheware, Atish , Srivastava, Mousami , Agrawal, Anurag , Bhatraju, Naveen Kumar , Bhatraju, Naveen Kumar , Pattnaik, Bijay , Prakash, Y. S.

Mayo Clinic

Physiological Reports | May 9, 2024 | Volume: 12 | Issue: 9 | Pages: No page available

10.14814/phy2.16032 | PMID 38720166 Get It

AbstractINPP4A has been shown to be involved in the regulation of cell proliferation and apoptosis of multiple cell types including fibroblasts. Previous reports from our group have demonstrated the role of inositol polyphosphate 4‐phosphatase Type I A (INPP4A) in these functions. Though existing evidences suggest a critical role for INPP4A in the maintenance of lung homeostasis, its role in chronic lung diseases is relatively under explored. In the current study, we made an attempt to understand the regulation of INPP4A in idiopathic pulmonary fibrosis (IPF). Through integration of relevant INPP4A gene expression data from public repositories with our results from in vitro experiments and mouse models, we show that INPP4A is altered in IPF. Interestingly, the direction of the change is dependent both on the disease stage and the region of the lung used. INPP4A was found to be upregulated when analyzed in lung sample representative of the whole lung, but was downregulated in the fibrotic regions of the lung. Similarly, INPP4A was found to be high, compared to controls, only in the early stage of the disease. Though the observed increase in INPP4A was found to be negatively correlated to physiological indices, FVC, and DLCO, of lung function, treatment with anti‐INPP4A antibody worsened the condition in bleomycin treated mice. These contrasting results taken together are suggestive of a nuanced regulation of INPP4A in IPF which is dependent on the disease stage, cellular state and extent of fibrosis in the lung region being analyzed.
Efficacy and safety of Endoscopic ultrasound-guided hepaticogastrostomy for biliary obstruction: A comprehensive systematic review, meta-analysis and meta-regression
Kumar, Naveen , Chhoda, Ankit , Aggarwal, Manik , Nabi, Zaheer, Lakhtakia, Sandeep, Dhar, Jahnvi , Nabi, Zaheer , Crinò, Stefano Francesco , Facciorusso, Antonio , Samanta, Jayanta

Mayo Clinic

Endoscopy | April 23, 2024 | Volume: 56 | Issue: S 02 | Pages: S449-S450

10.1055/s-0044-1783835 Get It

The aged microenvironment impairs BCL6 and CD40L induction in CD4+ T follicular helper cell differentiation
Fisher, Jacob S. , Adán‐Barrientos, Irene , Kumar, Naveen , Lancaster, Jessica N. , Kumar, Naveen R, Lancaster, Jessica N

Mayo Clinic

Aging Cell | March 14, 2024 | Volume: 23 | Issue: 6 | Pages: No page available

10.1111/acel.14140 | PMID 38481058 Get It

AbstractWeakened germinal center responses by the aged immune system result in diminished immunity against pathogens and reduced efficacy of vaccines. Prolonged contacts between activated B cells and CD4+ T cells are crucial to germinal center formation and T follicular helper cell (Tfh) differentiation, but it is unclear how aging impacts the quality of this interaction. Peptide immunization confirmed that aged mice have decreased expansion of antigen‐specific germinal center B cells and reduced antibody titers. Furthermore, aging was associated with accumulated Tfh cells, even in naïve mice. Despite increased numbers, aged Tfh had reduced expression of master transcription factor BCL6 and increased expression of the ectonucleotidase CD39. In vitro activation revealed that proliferative capacity was maintained in aged CD4+ T cells, but not the costimulatory molecule CD40L. When activated in vitro by aged antigen‐presenting cells, young CD4+ naïve T cells generated reduced numbers of activated cells with upregulated CD40L. To determine the contribution of cell‐extrinsic influences on antigen‐specific Tfh induction, young, antigen‐specific B and CD4+ T cells were adoptively transferred into aged hosts prior to peptide immunization. Transferred cells had reduced expansion and differentiation into germinal center B cell and Tfh and reduced antigen‐specific antibody titers when compared to young hosts. Young CD4+ T cells transferred aged hosts differentiated into Tfh cells with reduced PD‐1 and BCL6 expression, and increased CD39 expression, though they maintained their mitochondrial capacity. These results highlight the role of the lymphoid microenvironment in modulating CD4+ T cell differentiation, which contributes to impaired establishment and maintenance of germinal centers.
Author response to letter to editor: Hyperinsulinemia adversely affects lung structure and function
Singh, Suchita, Bhatraju, Naveen Kumar , Pattnaik, Bijay , Gheware, Atish , Parameswaran, Praveen Kolumam, Thompson, Michael , Freeman, Michelle, Mabalirajan, Ulaganathan , Gosens, Reinoud , Ghosh, Balaram , Linneberg, Allan , Prakash, Y. S. , Agrawal, Anurag , Pabelick, Christina, Bodas, Manish , Pabelick, Christina M. , Prakash, Y S , Gosens, Reinoud , Bhatraju, Naveen Kumar

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | July 13, 2016 | Volume: 311 | Issue: 1 | Pages: L183-L184

10.1152/ajplung.00227.2016 | PMID 27407082 Get It

Hyperinsulinemia adversely affects lung structure and function
Singh, Suchita, Bhatraju, Naveen Kumar , Pattnaik, Bijay , Gheware, Atish , Parameswaran, Praveen Kolumam, Freeman, Michelle, Mabalirajan, Ulaganathan , Gosens, Reinoud , Ghosh, Balaram , Linneberg, Allan , Prakash, Y. S. , Agrawal, Anurag , Pabelick, Christina, Bodas, Manish , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Gosens, Reinoud , Bhatraju, Naveen Kumar

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | February 26, 2016 | Volume: 310 | Issue: 9 | Pages: L837-L845

10.1152/ajplung.00091.2015 | PMID 26919895 Get It

There is limited knowledge regarding the consequences of hyperinsulinemia on the lung. Given the increasing prevalence of obesity, insulin resistance, and epidemiological associations with asthma, this is a critical lacuna, more so with inhaled insulin on the horizon. Here, we demonstrate that insulin can adversely affect respiratory health. Insulin treatment (1 μg/ml) significantly ( P < 0.05) increased the proliferation of primary human airway smooth muscle (ASM) cells and induced collagen release. Additionally, ASM cells showed a significant increase in calcium response and mitochondrial respiration upon insulin exposure. Mice administered intranasal insulin showed increased collagen deposition in the lungs as well as a significant increase in airway hyperresponsiveness. PI3K/Akt mediated activation of β-catenin, a positive regulator of epithelial-mesenchymal transition and fibrosis, was observed in the lungs of insulin-treated mice and lung cells. Our data suggests that hyperinsulinemia may have adverse effects on airway structure and function. Insulin-induced activation of β-catenin in lung tissue and the contractile effects on ASM cells may be causally related to the development of asthma-like phenotype.
Headaches due to giant cell arteritis following herpes zoster ophthalmicus in an elderly patient
Kosa, SC, Younge, BR, Kumar, Naveen

Mayo Clinic

Cephalalgia | May 1, 2009 | Volume: 30 | Issue: 2 | Pages: 239-241

10.1111/j.1468-2982.2009.01880.x | PMID 19438922 Get It

Herpes zoster ophthalmicus (HZO) with post-herpetic neuralgia (PHN) and giant cell arteritis (GCA) are two diseases more commonly seen in the elderly population. Each has potentially serious and preventable visual complications by differing mechanisms. Treatments for the two diseases differ. Antiviral medications are used in HZO and high-dose corticosteroids in GCA. These two entities could potentially coexist in the same patient, leading to a complicated diagnostic scenario where a potentially treatable disease could be overlooked. Here, we report a patient who was suffering from PHN following zoster ophthalmicus who developed GCA within a time frame suggesting a potential pathogenic association with the reactivation of latent varicella zoster virus (VZV). This association could be either direct with viral vessel infiltration leading to the arteritis or by an indirect dysimmune route. A pathophysiological association with VZV leading to the development of GCA is proposed.